Acute Myeloid Leukemia in a Patient With X-linked Severe Combined Immunodeficiency

被引：1

作者：

Shigemura, Tomonari ^{[1
]}

Motobayashi, Mitsuo ^{[1
]}

Matsuda, Kazuyuki ^{[2
]}

Shimodaira, Takahiro ^{[2
]}

Kurata, Takashi ^{[1
]}

Kobayashi, Norimoto ^{[1
]}

Agematsu, Kazunaga ^{[3
]}

Nakazawa, Yozo ^{[1
]}

机构：

[1] Shinshu Univ, Sch Med, Dept Pediat, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan

[2] Shinshu Univ Hosp, Dept Lab Med, Matsumoto, Nagano, Japan

[3] Shinshu Univ, Grad Sch Med, Dept Infect & Host Def, Matsumoto, Nagano, Japan

来源：

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 2017年 / 39卷 / 08期

关键词：

severe combined immunodeficiency; acute myeloid leukemia; cord blood transplantation; loss of heterozygosity; NRAS mutation; 6q deletion; CANCER; PATHWAY; REGIONS; 6Q;

D O I：

10.1097/MPH.0000000000000892

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Severe combined immunodeficiency (SCID) is a defect in the differentiation and function of T cells. An increased malignancy risk, mainly lymphatic malignancy, has been described in patients with SCID. We report a patient with X-linked SCID who developed acute myeloid leukemia, derived from the recipient with somatic NRAS mutation 4 months after cord blood transplantation (CBT). Loss of heterozygosity phenomenon of the recipient at 6q14 locus was observed at 2 months post-CBT and progressed to 6q deletion (6q-) chromosome abnormality. Somatic NRAS mutation was detected at 3 months post-CBT. Thus, 6q- and NRAS mutation were strongly associated with the leukemic transformation in our patient.

引用

页码：E470 / E472

页数：3

共 50 条

[41] Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China
Zhang, Cui
Zhang, Zhi-Yong
Wu, Jun-Feng
Tang, Xue-Mei
Yang, Xi-Qiang
Jiang, Li-Ping
Zhao, Xiao-Dong
WORLD JOURNAL OF PEDIATRICS, 2013, 9 (01) : 42 - 47
[42] Different Clinical Phenotypes in 2 Siblings With X-Linked Severe Combined Immunodeficiency
Wada, T.
Toma, T.
Yasui, M.
Inoue, M.
Kawa, K.
Imai, K.
Morio, T.
Yachie, A.
JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY, 2016, 26 (01) : 63 - 65
[43] Treatment of an X-linked severe combined immunodeficiency by γc-gene transfer
Borensztein, P
Cramer, E
Coulombel, L
Gilgenkrantz, S
Levy, Y
Lotteau, V
M S-MEDECINE SCIENCES, 2000, 16 (05): : 681 - 684
[44] Retroviral-mediated gene correction for X-linked severe combined immunodeficiency
Candotti, F
Johnston, JA
Puck, JM
Sugamura, K
OShea, JJ
Blaese, M
BLOOD, 1996, 87 (08) : 3097 - 3102
[45] Postnatal development of T cells in dogs with X-linked severe combined immunodeficiency
Somberg, RL
Tipold, A
Hartnett, BJ
Moore, PF
Henthorn, PS
Felsburg, PJ
JOURNAL OF IMMUNOLOGY, 1996, 156 (04): : 1431 - 1435
[46] RETROVIRAL VECTOR SYSTEMS FOR THE CORRECTION OF X-LINKED SEVERE COMBINED IMMUNODEFICIENCY (XSCID)
KLEIMAN, SE
ISAKOV, J
SEIDEL, N
BODINE, D
PASTAN, I
GOTTESMAN, MM
PUCK, JM
AMERICAN JOURNAL OF HUMAN GENETICS, 1995, 57 (04) : 1413 - 1413
[47] AN INTRINSIC B-CELL DEFECT IN X-LINKED SEVERE COMBINED IMMUNODEFICIENCY
CONLEY, ME
GUERRA, C
PUCK, JM
CLINICAL RESEARCH, 1987, 35 (03): : A606 - A606
[48] Gene Therapy Studies in a Canine Model of X-Linked Severe Combined Immunodeficiency
Felsburg, Peter J.
De Ravin, Suk See
Malech, Harry L.
Sorrentino, Brian P.
Burtner, Christopher
Kiem, Hans-Peter
HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2015, 26 (01) : 50 - 56
[49] Thymic microenvironment abnormalities in X-linked severe combined immunodeficiency syndrome.
Hale, LP
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2002, 118 (04) : 633 - 633
[50] Clinical characteristics and mutation analysis of X-linked severe combined immunodeficiency in China
Cui Zhang
Zhi-Yong Zhang
Jun-Feng Wu
Xue-Mei Tang
Xi-Qiang Yang
Li-Ping Jiang
Xiao-Dong Zhao
World Journal of Pediatrics, 2013, 9 : 42 - 47

← 1 2 3 4 5 →